Protein Binding Assays Market by Technology, End User - Global Forecast to 2023

Introduction

“The global protein binding assay market is projected to grow at a CAGR of 10.7%.”

The protein binding assay market is projected to reach USD 425.7 million in 2023 from USD 256.1 million in 2018, at CAGR of 10.7% during the forecast period. Factors such as the growing number of drug discovery activities, increasing pressure to reduce drug discovery and development costs, and the increase in pharmaceutical R&D expenditure are driving market growth. Issues concerning existing technologies and the development of in silico-based prediction models are expected to challenge market growth to a certain extent.

“Pharmaceutical and biotechnology companies are expected to account for the largest share of the protein binding assay market in 2018.”

By end user, the protein binding assay market is divided into pharmaceutical & biotechnology companies, CROs, and other end users. In 2018, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the protein binding assay market. Protein binding assays play a pivotal role in ADME procedures, owing to which they are widely used by pharmaceutical & biotechnology companies to evaluate drug candidates based on their binding capacity with proteins.

“The equilibrium dialysis segment is expected to dominate the market in 2018.”

On the basis of technology, the protein binding assay market is segmented into equilibrium dialysis, ultrafiltration, ultracentrifugation, and other technologies. The equilibrium dialysis segment is expected to account for the largest share of the protein binding assay market. The large share and high growth rate of this segment can be attributed to the advantages associated with the use of equilibrium dialysis, which include physical simplicity, low costs, and high accuracy. The simpler workflow equilibrium dialysis also makes it the preferred choice for protein binding studies.

“North America is expected to account for the largest share of the market in 2018.”

By geography, North America is expected to account for the largest share of the protein binding assay market in 2018, followed by Europe. The well-established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investments in North America are the key drivers for this regional market.

Break-up profile of primaries:

• By Company Type- Tier 1-33%, Tier 2-40% and Tier 3-27%

• By Designation- C-level-21%, D-level-36% and Others-43%

• By Region- North America-43%, Europe-31%, Asia Pacific-18%, and RoW-8%

The key players operating in the protein binding assay market are Thermo Fisher Scientific (US), GE Healthcare (US), Danaher (US), and Merck (Germany).

Research Coverage:

The protein binding assay market in this report is segmented by technology and end user. The study tracks and analyzes competitive developments such as product launches, collaborations, agreements, partnerships, and acquisitions. It also profiles key players and their core competencies in the protein binding assay market.

Reasons to buy this report:

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the portfolios offered by the top players in the protein binding assay market

• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global protein binding assay market

• Market Development: Comprehensive information about lucrative emerging markets—the report analyzes markets for protein binding assay products across regions

• Market Diversification: Exhaustive information about new products, untapped geographies, and recent developments in the market

• Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global protein binding assay market

Table of Contents
for Protein Binding Assays Market by Technology (Equillibrium Dialysis, Ultrafiltration, Ultracentrifugation, Gel Filtration Chromatography), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization) - Global Forecast to 2023

• TABLE OF CONTENTS

  1 INTRODUCTION 12

  1.1 OBJECTIVES OF THE STUDY 12

  1.2 MARKET DEFINITION 12

  1.3 MARKET SCOPE 13

  1.3.1 MARKETS COVERED 13

  1.3.2 YEARS COVERED FOR THE STUDY 14

  1.4 CURRENCY 14

  1.5 LIMITATIONS 14

  1.6 STAKEHOLDERS 14

  2 RESEARCH METHODOLOGY 15

  2.1 RESEARCH DATA 15

  2.1.1 SECONDARY DATA 16

  2.1.1.1 Key data from secondary sources 16

  2.1.2 PRIMARY DATA 17

  2.1.2.1 Key data from primary sources 17

  2.1.2.2 Key industry insights 18

  2.2 MARKET SIZE ESTIMATION 19

  2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 22

  2.4 ASSUMPTIONS FOR THE STUDY 23

  3 EXECUTIVE SUMMARY 24

  4 PREMIUM INSIGHTS 27

  4.1 PROTEIN BINDING ASSAY: MARKET OVERVIEW 27

  4.2 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY & COUNTRY (2018) 28

  4.3 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY (2018 VS. 2023) 28

  4.4 GEOGRAPHIC SNAPSHOT OF THE PROTEIN BINDING ASSAY MARKET 29

  5 MARKET OVERVIEW 30

  5.1 INTRODUCTION 30

  5.2 MARKET DYNAMICS 30

  5.2.1 DRIVERS 31

  5.2.1.1 Rise in drug discovery activities 31

  5.2.1.2 Growing pressure to reduce drug discovery and development costs 31

  5.2.1.3 Increase in pharmaceutical R&D expenditure 31

  5.2.2 RESTRAINTS 32

  5.2.2.1 Issues with existing technologies 32

   

  5.2.3 OPPORTUNITIES 32

  5.2.3.1 Growing CRO Industry 32

  5.2.4 CHALLENGES 33

  5.2.4.1 Development of in silico-based prediction models 33

  6 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY 34

  6.1 INTRODUCTION 35

  6.2 EQUILIBRIUM DIALYSIS 36

  6.3 ULTRAFILTRATION 38

  6.4 ULTRACENTRIFUGATION 40

  6.5 OTHER TECHNOLOGIES 42

  7 PROTEIN BINDING ASSAY MARKET, BY END USER 44

  7.1 INTRODUCTION 45

  7.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 46

  7.3 CONTRACT RESEARCH ORGANIZATIONS 48

  7.4 OTHER END USERS 50

  8 PROTEIN BINDING ASSAY MARKET, BY REGION 52

  8.1 INTRODUCTION 53

  8.2 NORTH AMERICA 55

  8.2.1 US 57

  8.2.2 CANADA 59

  8.3 EUROPE 60

  8.3.1 GERMANY 61

  8.3.2 UK 62

  8.3.3 FRANCE 63

  8.3.4 REST OF EUROPE 64

  8.4 ASIA PACIFIC 65

  8.4.1 CHINA 67

  8.4.2 INDIA 68

  8.4.3 REST OF ASIA PACIFIC 69

  8.5 REST OF THE WORLD 71

  9 COMPETITIVE LANDSCAPE 72

  9.1 MARKET OVERVIEW 72

  9.2 MARKET RANKING ANALYSIS, 2018 72

  9.3 COMPETITIVE SITUATION AND TRENDS 73

  9.3.1 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS 73

  9.3.2 ACQUISITIONS 73

   

  10 COMPANY PROFILES 74

  (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  10.1 MERCK 74

  10.2 THERMO FISHER SCIENTIFIC 76

  10.3 GE HEALTHCARE 78

  10.4 SOVICELL GMBH 81

  10.5 ABSORPTION SYSTEMS 82

  10.6 HTDIALYSIS 83

  10.7 EUROFINS SCIENTIFIC 84

  10.8 ADMECELL 86

  10.9 3B PHARMACEUTICALS 87

  10.10 BIOTIUM 88

  10.11 DANAHER CORPORATION 89

  *Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

  11 APPENDIX 91

  11.1 INSIGHTS OF INDUSTRY EXPERTS 91

  11.2 DISCUSSION GUIDE 92

  11.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 94

  11.4 AVAILABLE CUSTOMIZATIONS 96

  11.5 RELATED REPORTS 96

  11.6 AUTHOR DETAILS 97

List Of Tables
in Protein Binding Assays Market by Technology, End User - Global Forecast to 2023

LIST OF TABLES

TABLE 1 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 35

TABLE 2 PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY, PROTEIN BINDING VIALS/TUBES (UNITS) 35

TABLE 3 PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS,

BY REGION, 2016–2023 (USD MILLION) 36

TABLE 4 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS, BY COUNTRY, 2016–2023 (USD MILLION) 36

TABLE 5 EUROPE: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS,

BY COUNTRY, 2016–2023 (USD MILLION) 37

TABLE 6 APAC: PROTEIN BINDING ASSAY MARKET FOR EQUILIBRIUM DIALYSIS,

BY COUNTRY, 2016–2023 (USD MILLION) 37

TABLE 7 PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION, BY REGION,

2016–2023 (USD MILLION) 38

TABLE 8 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION,

BY COUNTRY, 2016–2023 (USD MILLION) 38

TABLE 9 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION,

BY COUNTRY, 2016–2023 (USD MILLION) 39

TABLE 10 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRAFILTRATION,

BY COUNTRY, 2016–2023 (USD MILLION) 39

TABLE 11 PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION,

BY REGION, 2016–2023 (USD MILLION) 40

TABLE 12 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION, BY COUNTRY, 2016–2023 (USD MILLION) 40

TABLE 13 EUROPE: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION,

BY COUNTRY, 2016–2023 (USD MILLION) 41

TABLE 14 APAC: PROTEIN BINDING ASSAY MARKET FOR ULTRACENTRIFUGATION,

BY COUNTRY, 2016–2023 (USD MILLION) 41

TABLE 15 PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES,

BY REGION, 2016–2023 (USD MILLION) 42

TABLE 16 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION) 42

TABLE 17 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2016–2023 (USD MILLION) 43

TABLE 18 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER TECHNOLOGIES,

BY COUNTRY, 2016–2023 (USD MILLION) 43

TABLE 19 PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION) 45

TABLE 20 PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016–2023 (USD MILLION) 46

TABLE 21 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 47

TABLE 22 EUROPE: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 47

TABLE 23 APAC: PROTEIN BINDING ASSAY MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016–2023 (USD MILLION) 47

TABLE 24 PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2016–2023 (USD MILLION) 48

TABLE 25 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 48

TABLE 26 EUROPE: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 49

TABLE 27 APAC: PROTEIN BINDING ASSAY MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 49

TABLE 28 PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS,

BY REGION, 2016–2023 (USD MILLION) 50

TABLE 29 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS,

BY COUNTRY, 2016–2023 (USD MILLION) 50

TABLE 30 EUROPE: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS,

BY COUNTRY, 2016–2023 (USD MILLION) 51

TABLE 31 APAC: PROTEIN BINDING ASSAY MARKET FOR OTHER END USERS,

BY COUNTRY, 2016–2023 (USD MILLION) 51

TABLE 32 PROTEIN BINDING ASSAY MARKET, BY REGION, 2016–2023 (USD MILLION) 53

TABLE 33 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 53

TABLE 34 EUROPE: PROTEIN BINDING ASSAY MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 54

TABLE 35 APAC: PROTEIN BINDING ASSAY MARKET, BY COUNTRY,

2016–2023 (USD MILLION) 54

TABLE 36 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET,

BY TECHNOLOGY, 2016–2023 (USD MILLION) 57

TABLE 37 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET,

BY END USER, 2016–2023 (USD MILLION) 57

TABLE 38 US: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 58

TABLE 39 US: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION) 58

TABLE 40 CANADA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 59

TABLE 41 CANADA: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 59

TABLE 42 EUROPE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 60

TABLE 43 EUROPE: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 60

TABLE 44 GERMANY: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 61

TABLE 45 GERMANY: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 61

TABLE 46 UK: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 62

TABLE 47 UK: PROTEIN BINDING ASSAY MARKET, BY END USER, 2016–2023 (USD MILLION) 62

TABLE 48 FRANCE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 63

TABLE 49 FRANCE: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 63

TABLE 50 ROE: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 64

TABLE 51 ROE: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 65

TABLE 52 APAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 67

TABLE 53 APAC: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 67

TABLE 54 CHINA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 68

TABLE 55 CHINA: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 68

TABLE 56 INDIA: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 69

TABLE 57 INDIA: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 69

TABLE 58 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 70

TABLE 59 ROAPAC: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 70

TABLE 60 ROW: PROTEIN BINDING ASSAY MARKET, BY TECHNOLOGY,

2016–2023 (USD MILLION) 71

TABLE 61 ROW: PROTEIN BINDING ASSAY MARKET, BY END USER,

2016–2023 (USD MILLION) 71

TABLE 62 COLLABORATIONS, AGREEMENTS, AND PARTNERSHIPS, 2015–2018 73

TABLE 63 ACQUISITIONS, 2015-2018 73

List Of Figures, Charts and Diagrams
in Protein Binding Assays Market by Technology, End User - Global Forecast to 2023

LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 15

FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,

AND REGION 19

FIGURE 3 BOTTOM-UP APPROACH 20

FIGURE 4 TOP-DOWN APPROACH 21

FIGURE 5 DATA TRIANGULATION METHODOLOGY 22

FIGURE 6 EQUILIBRIUM DIALYSIS TOP REGISTER THE HIGHEST GROWTH IN THE MARKET DURING THE FORECAST PERIOD 24

FIGURE 7 PHARMACEUTICAL & BIOTECHNOLOGY TO DOMINATE THE MARKET DURING THE FORECAST PERIOD 25

FIGURE 8 GEOGRAPHIC SNAPSHOT OF PROTEIN BINDING ASSAY MARKET 26

FIGURE 9 INCREASING DRUG DISCOVERY ACTIVITIES—THE PRIMARY GROWTH DRIVER OF THE PROTEIN BINDING ASSAY MARKET 27

FIGURE 10 EQUILIBRIUM DIALYSIS TO CONTINUE TO DOMINATE THE PROTEIN BINDING ASSAY MARKET IN THE FORECAST PERIOD 28

FIGURE 11 APAC TO BE THE FASTEST-GROWING MARKET FROM 2018 TO 2023 29

FIGURE 12 PROTEIN BINDING ASSAY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES 30

FIGURE 13 GLOBAL PHARMACEUTICAL R&D SPENDING (2010–2024) 32

FIGURE 14 NORTH AMERICA: PROTEIN BINDING ASSAY MARKET SNAPSHOT 56

FIGURE 15 ASIA PACIFIC: PROTEIN BINDING ASSAY MARKET SNAPSHOT 66

FIGURE 16 RANK OF COMPANIES IN THE PROTEIN BINDING ASSAY MARKET, 2018 72

FIGURE 17 MERCK: COMPANY SNAPSHOT (2017) 74

FIGURE 18 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2017) 76

FIGURE 19 GE HEALTHCARE: COMPANY SNAPSHOT (2017) 78

FIGURE 20 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2017) 84

FIGURE 21 DANAHER CORPORATION: COMPANY SNAPSHOT (2017) 89

Additional Details

Publisher

MarketsandMarkets

Publisher Information

Reference

218154 | BT 6524

Number of Pages

98

Report Format

PDF

Related Reports